Eye doctors urge GLP-1 drug caution
US$ 21.72
cagrilintide semaglutide combination phase 3 2024 CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 REDEFINE 1 Trial Finds Cagrilintide–Semaglutide
Description
Average WL of 10% to 15% has been shown to signifi- cantly alleviate many complications associated with obesity, includ- ing diabetes, hypertension, osteoarthritis, and gastroesophageal reflex disease (40-42)
It is unclear why directionality would vary between studies, although we note these studies were performed in specific disease contexts, and are in substantially smaller samples
Metformin may decrease cancer risk, whereas insulin and sulfonylureas could elevate such risks [3]
Researchers should consider this when calculating their dosing protocols
As of today, August 14, 2023, I weigh 142 pounds
